Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding

> Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding

               Online Conference Center

Return to Vaccination News Home Page  __»   Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://www.ajcn.org/cgi/content/abstract/78/2/291

American Journal of Clinical Nutrition, Vol. 78, No. 2, 291-295, August 2003
© 2003 American Society for Clinical Nutrition

 


ORIGINAL RESEARCH COMMUNICATION

Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding1,2,3

Michael S Kramer, Tong Guo, Robert W Platt, Zinaida Sevkovskaya, Irina Dzikovich, Jean-Paul Collet, Stanley Shapiro, Beverley Chalmers, Ellen Hodnett, Irina Vanilovich, Irina Mezen, Thierry Ducruet, George Shishko and Natalia Bogdanovich

1 From the Departments of Pediatrics (MSK, RWP, and J-PC) and Epidemiology and Biostatistics (MSK, TG, RWP, J-PC, SS, and TD), McGill University Faculty of Medicine, Montreal; the Centre for Research in Women’s Health (BC), Sunnybrook Women’s College Health Sciences Centre (BC), and Faculty of Nursing (EH), University of Toronto; the Departments of Maternal and Child Health (ZS) and Foreign Relations (IM), Belarussian Ministry of Health, Minsk, Belarus; and the Belarussian Maternal and Child Health Research Institute (ID, IV, GS, and NB), Minsk, Belarus.

 

Background: Opinions and recommendations about the optimal duration of exclusive breastfeeding have been strongly divided, but few published studies have provided direct evidence on the relative risks and benefits of different breastfeeding durations in recipient infants.

Objective: We examined the effects on infant growth and health of 3 compared with 6 mo of exclusive breastfeeding.

Design: We conducted an observational cohort study nested within a large randomized trial in Belarus by comparing 2862 infants exclusively breastfed for 3 mo (with continued mixed breastfeeding through >= 6 mo) with 621 infants who were exclusively breastfed for >= 6 mo. Regression to the mean, within-cluster correlation, and cluster- and individual-level confounding variables were accounted for by using multilevel regression analyses.

Results: From 3 to 6 mo, weight gain was slightly greater in the 3-mo group [difference: 29 g/mo (95% CI: 13, 45 g/mo)], as was length gain [difference: 1.1 mm (0.5, 1.6 mm)], but the 6-mo group had a faster length gain from 9 to 12 mo [difference: 0.9 mm/mo (0.3, 1.5 mm/mo)] and a larger head circumference at 12 mo [difference: 0.19 cm (0.07, 0.31 cm)]. A significant reduction in the incidence density of gastrointestinal infection was observed during the period from 3 to 6 mo in the 6-mo group [adjusted incidence density ratio: 0.35 (0.13, 0.96)], but no significant differences in risk of respiratory infectious outcomes or atopic eczema were apparent.

Conclusions: Exclusive breastfeeding for 6 mo is associated with a lower risk of gastrointestinal infection and no demonstrable adverse health effects in the first year of life.

Key Words: Breastfeeding • gastrointestinal infection • respiratory infection • growth • atopic eczema


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Copyright © 2003 by The American Society for Clinical Nutrition, Inc.

 

Return to Vaccination News Home Page  __»   Right-click to "open in new window"

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.